Literature DB >> 16054995

Optical coherence tomography imaging of the anterior chamber angle.

Sunita Radhakrishnan1, David Huang, Scott D Smith.   

Abstract

Primary angle closure glaucoma is a common cause of visual loss worldwide. Gonioscopy and other current methods of assessment of the anatomy of the anterior segment relevant to the diagnosis of this disease, such as ultrasound biomicroscopy, have significant limitations. Anterior segment optical coherence tomography, with its rapid, noncontact, and high-resolution image acquisition, seems to be a promising tool for the evaluation of the anterior chamber angle configuration, including changes induced by illumination and laser peripheral iridotomy. It has the potential for use as a rapid screening tool for detection of occludable angles. Ongoing clinical studies should help to evaluate its efficacy in this regard.

Entities:  

Mesh:

Year:  2005        PMID: 16054995     DOI: 10.1016/j.ohc.2005.05.007

Source DB:  PubMed          Journal:  Ophthalmol Clin North Am        ISSN: 0896-1549


  23 in total

1.  Optical coherence tomography of the anterior segment in secondary glaucoma with corneal opacity after penetrating keratoplasty.

Authors:  Farnaz Memarzadeh; Yan Li; Brian A Francis; Ronald E Smith; Julie Gutmark; David Huang
Journal:  Br J Ophthalmol       Date:  2006-09-14       Impact factor: 4.638

2.  Detailed visualization of the anterior segment using fourier-domain optical coherence tomography.

Authors:  Sanjay Asrani; Marinko Sarunic; Cecilia Santiago; Joseph Izatt
Journal:  Arch Ophthalmol       Date:  2008-06

3.  Role of lens vault in subtypes of angle closure in Iranian subjects.

Authors:  S Moghimi; Z Vahedian; N Zandvakil; M Mohammdi; G Fakhraie; N Nassiri; A L Coleman; S Lin
Journal:  Eye (Lond)       Date:  2014-01-10       Impact factor: 3.775

Review 4.  Optical coherence tomography: history, current status, and laboratory work.

Authors:  Michelle L Gabriele; Gadi Wollstein; Hiroshi Ishikawa; Larry Kagemann; Juan Xu; Lindsey S Folio; Joel S Schuman
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-14       Impact factor: 4.799

5.  Agreement of angle closure assessments between gonioscopy, anterior segment optical coherence tomography and spectral domain optical coherence tomography.

Authors:  Elton Lik Tong Tay; Vernon Khet Yau Yong; Boon Ang Lim; Stelson Sia; Elizabeth Poh Ying Wong; Leonard Wei Leon Yip
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

6.  Identification and biometry of horizontal extraocular muscle tendons using optical coherence tomography.

Authors:  Guillermo Salcedo-Villanueva; Miguel Paciuc-Beja; Mariana Harasawa; Raul Velez-Montoya; Jeffrey L Olson; Scott C Oliver; Naresh Mandava; Hugo Quiroz-Mercado
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-12-03       Impact factor: 3.117

7.  Determinants of anterior chamber angle narrowing after mydriasis in the patients with cataract.

Authors:  Shogo Arimura; Yoshihiro Takamura; Yuji Takihara; Takehiro Matsumura; Takeshi Tomomatsu; Masaru Inatani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-10-14       Impact factor: 3.117

8.  Sectoral variations of iridocorneal angle width and iris volume in Chinese Singaporeans: a swept-source optical coherence tomography study.

Authors:  Tin A Tun; Mani Baskaran; Shamira A Perera; Anita S Chan; Ching-Yu Cheng; Hla M Htoon; Lisandro M Sakata; Carol Y Cheung; Tin Aung
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-04-30       Impact factor: 3.117

9.  Anterior chamber measurements by pentacam and AS-OCT in eyes with normal open angles.

Authors:  Jeong-Ho Yi; Samin Hong; Gong Je Seong; Sung Yong Kang; Kyoung Tak Ma; Chan Yun Kim
Journal:  Korean J Ophthalmol       Date:  2008-12

10.  Detection of occludable angles with the Pentacam and the anterior segment optical coherence tomography.

Authors:  Samin Hong; Jeong-Ho Yi; Sung Yong Kang; Gong Je Seong; Chan Yun Kim
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.